Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins

European Journal of Vascular and Endovascular Surgery

Volumn 27, Issue 1, 2004, Pages 75-79

  Warsi, A A ^a,c   Davies, B ^b   Morris Stiff, G ^a   Hullin, D ^a   Lewis, M H ^a  

^a ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLAMORGAN   (United Kingdom)

^c KETTERING GENERAL HOSPITAL   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Total plasma homocysteine; Vitamin B12 and folic acid

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG RESEARCH; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0348155667     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2003.09.001     Document Type: Article

References (37)

1. Fortin LJ, Genest Jr J. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem 1995; 28: 155-162.
2. Gibson JB, Carson NAJ, Neill DW. Pathological findings in homocystinuria. J Clin Pathol 1964; 17: 427-437.
3. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128.
4. Shimke RN, McKusik VA, Huang T. Homocystinuria: studies of 20 families with 38 affected members. JAMA 1965; 193: 711-719.
5. Harker LA, Ross R, Slichter SJ, Scott CR. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731-741.
6. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-1082.
7. Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-1016.
8. Boers GH, Smals AG, Trijbels FJ et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-715.
9. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
10. Boushey CJ, Shirley AA, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057.
11. Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-1781.
12. Brunelli T, Prisco D, Fedi S et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000; 32: 531-536.
13. Almgren B, Eriksson I, Hemmingsson A, Hillerdal G, Larson E, Aberg H. Abdominal aortic aneurysm in homocysteinuria. Acta Chir Scan 1978; 144: 545-548.
14. Colwell N, Clarke R, Robinson K, Keane F, O'Briain S, Graham I. Hyperhomocysteinaemia and multiple aneurysms. Postgrad Med J 1991; 67: 186-188.
15. Mohan IV, Adam DJ, Kurian KM, Ruckley CV. Isolated external iliac aneurysm associated with hyperhomocysteinaemia. Eur J Vasc Endovasc Surg 1997; 14: 506-508.
16. Ueland P, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Clin Med 1989; 114: 473-501.
17. McCully KS. Homocysteine and vascular disease. Annu Rev Nutr 1992; 12: 279-298.
18. Konecky N, Malinow MR, Tunick PA et al. Correlation between plasma homocyst(e)ine and aortic atherosclerosis. Am Heart J 1997; 133: 534-540.
19. Bescond A, Augier T, Chareyre C, Charpiot P, Garcon D. Homocysteine-induced elastolysis in arterial media: activation of MMP-2. Neth J Med 1998; 58: S56-S57.
20. Jourdheuil-Rahmani D, Roland PH, Rosset E, Branchereau A, Garcon D. Homocysteine induces synthesis of serine elastase in arterial smooth muscle cells from multi-organ donors. Cardiovasc Res 1997; 34: 597-602.
21. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987; 65: 13-21.
22. Stamler JS, Osborne JA, Jaraki O et al. Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-318.
23. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur Heart J 1999; 20: 1234-1244.
24. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22: 79-87.
25. Kawashiri M, Kajinami K, Nohara A et al. Plasma homecysteine level and development of coronary artery disease. Coron Artery Dis 1999; 10: 443-447.
26. Currie IC, Wilson YG, Scott J et al. Homocysteine: an independent risk factor for the failure of vascular intervention. Br J Surg 1996; 83: 1238-1241.
27. Lupattelli G, Rufini S, Locati EH et al. Hyperhomocyst(e)inemia is associated with carotid atherosclerosis. Angiology 1999; 50: 823-830.
28. Selhub J, Jacques PF, Rosenberg IH et al. Serum total homocysteine concentrations in the third National Health and Nutrition Survey (1994-1998): population reference ranges and contribution of vitamin status to high serum concentration. Ann Intern Med 1999; 131: 331-339.
29. Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997; 11: 217-223.
30. Quiroga I, Morris-Stiff G, Baboo R, Darby CR, Lord RH, Jurewicz WA. Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus. Transplant Proc 2001; 33: 1209-1210.
31. Jacobsen DW, Gatautis VJ, Green R. Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection. Anal Biochem 1989; 178: 208-214.
32. Koehler KM, Pareo-Tubbeh SL, Romero LJ, Baumgartner RN, Garry PJ. Folate nutrition and older adults: challenges and opportunities. J Am Diet Assoc 1997; 97: 167-173.
33. Koehler KM, Romero LJ, Stauber PM et al. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996; 15: 364-376.
34. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000; 102: 2479-2483.
35. Verhoef F, Stampfer MJ, Buring JE et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996; 143: 845-859.
36. Temple ME, Luzier AB, Kazierad DJ. Homocysteine as a risk factor for atherosclerosis. Ann Pharmacother 2000; 34: 57-65.
37. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomised trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000; 26: 341-348.